• Title of article

    Inhibition activity of sulfated polysaccharide of Sepiella maindroni ink on matrix metalloproteinase (MMP)-2

  • Author/Authors

    Subo Wang، نويسنده , , Yanna Cheng، نويسنده , , Fengshan Wang، نويسنده , , Lirui Sun، نويسنده , , Chunhui Liu، نويسنده , , Guanjun Chen، نويسنده , , Yuhua Li، نويسنده , , S.G. Ward، نويسنده , , Xianjun Qu، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2008
  • Pages
    6
  • From page
    297
  • To page
    302
  • Abstract
    SIP-SII is the sulfated S. maindroni ink polysaccharide (SIP) isolated from cuttlefish Sepiella maindroni. SIP-SII weakly inhibited tumor cell growth without cytotoxicity in vitro assay. Herein, we examined the effects of SIP-SII on the expression of matrix metalloproteinase MMP-2 and MMP-9 as well as tumor cell invasion and migration. SIP-SII (0.8–500 μg/ml) significantly decreased the expression of MMP-2 activity in human ovarian carcinoma cells SKOV3 as evidenced by the gelatin zymography analysis. No significant decrease of MMP-9 was detected in the cell line after SIP-SII treatment. The expression of MMP-2 was also evaluated using Western blot analysis. The results showed that SIP-SII inhibited the expression of MMP-2 in SKOV3 and human umbilical vein vascular endothelial cells ECV304 after 24 h incubation. Furthermore, the activity of invasion and migration of SKOV3 and ECV304 cells were measured. SIP-SII displayed an inhibitory effect on the penetration of SKOV3 cells through Matrigel-coated membrane in transwell chamber. A significant inhibition of ECV304 cell migration was observed in the presence of SIP-SII. These results suggest that SIP-SII might suppress invasion and migration of carcinoma cells via inhibition of MMP-2 proteolytic activity.
  • Keywords
    matrix metalloproteinases , migration , MMP-2 , S. maindroni ink polysaccharide (SIP) , Sulfated polysaccharide (SIP-SII) , Tumor invasion
  • Journal title
    Biomedicine and Pharmacotherapy
  • Serial Year
    2008
  • Journal title
    Biomedicine and Pharmacotherapy
  • Record number

    478072